Industry news

So What’s Holding Up a 100 Year-Old Super Bug Killer?

Ansis Helmanis / Pharmaceutical Executive

According to the Centers for Disease Control (CDC), about 2 million people fall victim to antibiotic resistant infections annually in this country and 23,000 die from those infections.  CDC’s Director has expressed concern that soon there may be no effective treatment for the growing number of antibiotic resistant super bugs.

New international alliance keen to attract global Russian-speaking scientists to Russia

MarchMont Innovation News

European Innovation Development Center (EIDC), a Russian biomed company developing biosensors for express immunodiagnostics, and the global Russian-speaking Academic Science Association (RASA) have pooled efforts in making Russia’s scientific environment attractive to Russian-speaking researchers around the world, the Skolkovo Foundation website  reported . 

Shanghai Pharmaceutical raises funds for online-to-offline sales push with eye on ethical products

EJ Lane / FeircePharmaAsia

A key drug company in China fired a new salvo in the online over-the-counter healthcare market with an eye on wider sales of ethical products in hopes the China Food and Drug Administration (CFDA) will come through on plans to allow online sales of prescription drugs at some point this year.

Larger VC funds underperforming across longer horizons

PitchBook Blog

Comparing VC horizon IRRs by size buckets yields considerably varied results. The lackluster performance of funds under $100 million in size overall, especially at the five-year horizon and beyond, makes sense, as the level of risk involved implies even the median will remain low on a long enough timescale.

Pharma TV ads are good for the business bottom line, study says

Beth Snyder Bulik / FiercePharmaMarketing

While pharma critics often complain about too much TV advertising, a new study says it might be money well spent--for companies and their shareholders, at least.

03 September 2015

Tragara Pharmaceuticals $13.06 million Financing. Thomas M Estok Filed Sep 1 SEC Form

Private Financing News

Tragara Pharmaceuticals, Inc., Corporation just had published form D about $13.06 million equity financing. This is a new filing. Tragara Pharmaceuticals was able to fundraise $13.06 million. That is 100.00% of the financing round. The total fundraising amount was $13.06 million. The financing document was filed on 2015-09-01. 

China Resilient: New Pharma Survey Offers Highly Positive Outlook

Cameron Sharp / Pharmaceutical Executive

Pharm Exec’s sister trade show company, UBM CPhI, has published its 2015 survey of the Chinese pharmaceutical market based on an opinion poll conducted with domestic and foreign suppliers attending CPhI’s annual China expo in Shanghai in late June. Despite some structural concerns in the context of slowing macro-economic growth overall, the report offers a very positive outlook on prospects for the industry in China.

Russian developers focus on new solution to fight viruses and allergies

MarchMont Innovation News

Nanolek, a Russian biotech firm based in the Kirov region in the Volga area, and the Moscow-based Mechnikov Research Institute of Vaccines and Serums, are pooling efforts in a project aimed at developing and commercializing a new immunobiology drug to fight viral diseases and allergies, the Rusnano website  reported .

Services grow in Singapore with Asian clinical, manufacturing biologics boom

EJ Lane / FeircePharmaAsia

Singapore has gathered pace as a place for companies in Asia to source services related to biologic clinical and manufacturing with recent additions in the city-state highlighting niches in a growing market.

Another recall by Indian drugmakers as U.S. FDA notes troubles

EJ Lane / FeircePharmaAsia

Two leading Indian drug firms once again face quality in manufacturing issues with the U.S. FDA, leading in this case to voluntary recalls even as both face extensive remedial actions to bring plants back into the good graces of the regulator.